This site uses cookies. By using this site you agree to receiving cookies. View Policy.

129%
Raised
£516,650
Investors
118
Target
£400,000
Equity
14.78%
Pre-money valuation
£2,978,344

Your back needs a hug. BackHug is a smart machine: its robotic fingers will sense and adapt to your back shape to give you individualised massage. You can book a session near you with your smartphone, as easily as an Uber, from £3. We are raising so everyone can have a BackHug anywhere, every day.

  • We estimate 1.1bn adults with sore back, offering a $30bn+ market
  • 40 units of the first version delivered to date with £58.5k revenue
  • Surveyed users report pain reduction with 72% average improvement
  • Customer testimonials say device's massage is better than manual

Idea

Around 1 billion people globally experience back pain. Manual therapy is expensive and requires users to travel, while existing massage devices use rollers and blocks, with limited benefit to the user. Pacla’s founder is an engineer who retrained as a physio. He developed a machine that replicates his manual massage with robotic fingers. Lie on the device and the robotic fingers will sense and adapt to your back shape to offer individualised treatment.

Pacla delivered 40 units for £58.5k revenue (FY18 net loss £177,470). All surveyed users report pain reduction, with an average improvement score of 72%. One year user engagement rate is 88%. Pacla’s founder's former manual physiotherapy customers who use the device say it’s better than his manual treatment.

BackHug is a smart new self-service device designed for offices, gyms, hotels and other locations where users can book sessions on them with an App – from £3 (like Uber for massages). Pacla also aims to develop technology to measure users' back tension changes, demonstrating BackHug’s benefits and optimising individual treatment with AI.

Having raised £640k in equity funding over two rounds since 2017, Pacla is raising to build 150 BackHugs. Its long term ambition is to install 10 million BackHugs globally, so everybody can afford a massage every day, creating a Serviceable Available Market opportunity of over $30bn.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Pacla Medical pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

Pacla Medical has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.